ALISertib in Patients with Extensive-Stage Small-Cell Lung Cancer: The Phase 2 ALISCA-Lung1 Study

被引：0

作者：

Owonikoko, T. ^{[1
]}

Burns, T. F. ^{[2
]}

Chiappori, A. A. ^{[3
]}

Drapkin, B. ^{[4
]}

Gentzler, R. D. ^{[5
]}

Goldschmidt, J. ^{[6
]}

Hakimian, D. ^{[7
]}

Jotte, R. ^{[8
]}

Liu, S. V. ^{[9
]}

Onitilo, A. A. ^{[10
]}

Pennell, N. A. ^{[11
]}

Potugari, B. ^{[12
]}

Rios, J. ^{[13
]}

Sands, J. ^{[14
]}

Spira, A. ^{[15
]}

Wang, B. ^{[16
]}

Waterhouse, D. M. ^{[17
]}

Lowenthal, B. ^{[18
]}

Bebchuk, J. ^{[18
]}

Eli, L. D. ^{[18
]}

Wong, E. K. ^{[18
]}

Dowlati, A. ^{[19
]}

机构：

[1] Univ Maryland, Baltimore, MD USA

[2] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[4] Univ Texas SouthWestern Med Ctr, Dallas, TX USA

[5] Univ Virginia, Charlottesville, VA USA

[6] US Oncol, Blue Ridge Canc Ctr, Blacksburg, VA USA

[7] US Oncol, Illinois Canc Specialists, Niles, IL USA

[8] Rocky Mt Canc Ctr, Lone Tree, CO USA

[9] Georgetown Univ, Washington, DC USA

[10] Marshfield Clin Wisconsin, Rapids, WI USA

[11] Cleveland Clin, Cleveland, OH USA

[12] Henry Ford Hosp, Detroit, MI USA

[13] Sarah Cannon Zangmeister Canc Ctr Columbus, Columbus, OH USA

[14] Dana Faber Canc Inst, Boston, MA USA

[15] Virginia Canc Specialists Res Inst, Fairfax, VA USA

[16] Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA

[17] OHC Oncol Hematol Care, Cincinnati, OH USA

[18] Puma Biotechnol, Los Angeles, CA USA

[19] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

Alisertib; Small-cell lung cancer; Aurora kinase A inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.13A.13

引用

页码：S212 / S213

页数：2

共 50 条

[41] Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer
Riedel, Richard F.
Crawford, Jeffrey
Dunphy, Frank
Herndon, James E., II
Garst, Jennifer
Kelley, Michael J.
LUNG CANCER, 2006, 54 (03) : 431 - 432
[42] Preliminary Results from a Phase Ib/II Trial of Belotecan plus Ifosfamide in Patients with Extensive-Stage Small-Cell Lung Cancer
Kim, Young Saing
Cho, Eun Kyung
Back, Min Young
Kim, Eun Young
Ahn, Hee Kyung
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S498 - S498
[43] Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer:: a Spanish Lung Cancer Group phase II study
Felip, E
Rosell, R
Domine, M
Santomé, L
Garrido, P
Font, A
Carrato, A
Terrasa, J
Vadell, C
Mañe, JM
Baselga, J
ANNALS OF ONCOLOGY, 2003, 14 (10) : 1549 - 1554
[44] Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer
Ramalingam, S
Belani, CP
Day, R
Zamboni, BA
Jacobs, SA
Jett, JR
ANNALS OF ONCOLOGY, 2004, 15 (02) : 247 - 251
[45] Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer
Perez, EA
Geoffroy, FJ
Hillman, S
Johnson, EA
Farr, GH
Tazelarr, HD
Hatfield, AK
Krook, JE
Maillard, JA
Levitt, R
Marks, RS
LUNG CANCER, 2004, 44 (03) : 347 - 353
[46] Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer
Spigel, David R.
Greco, F. Anthony
Rubin, Mark S.
Shipley, Dianna
Thompson, Dana S.
Lubiner, Eric T.
Eakle, Janice F.
Quinn, Raven
Burris, Howard A.
Hainsworth, John D.
LUNG CANCER, 2012, 77 (02) : 359 - 364
[47] Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer
Araujo, Antonio M. F.
Mendez, Jose C.
Coelho, Ana L.
Sousa, Berta
Barata, Fernando
Figueiredo, Ana
Amaro, Teresina
Azevedo, Isabel
Soares, Marta
CANCER INVESTIGATION, 2009, 27 (04) : 391 - 396
[48] Prognostic Laboratory Parameters in Imfirst: Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
de Castro, J.
Cobo Dols, M.
Domine Gomez, M.
Moreno Vega, A.
Ponce Aix, S.
Arriola, E.
Carcereny, E.
Majem, M.
Huidobro Vence, G.
Esteban Gonzalez, E.
Fuentes Pradera, J.
Ortega Granados, A. L.
Guillot Morales, M.
Massuti Sureda, B.
Fernandez Nunez, N.
Provencio, M.
Gonzalez-Mancha, N.
Fajardo, C. A.
Lerones, N.
Garcia Campelo, R.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S662 - S663
[49] Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world setting
Sands, Jacob
Subramanian, Janakiraman
FRONTIERS IN ONCOLOGY, 2023, 13
[50] Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US
Wang, Yingcheng
Rui, Mingjun
Yang, Lan
Wang, Xintian
Shang, Ye
Ma, Aixia
Li, Hongchao
FRONTIERS IN PUBLIC HEALTH, 2021, 9

← 1 2 3 4 5 →